PreserVision

Bausch + Lomb, Madison, NJ, has launched PreserVision Eye Vitamin and Mineral Supplement AREDS 2 formula. The product builds on the original clinically proven Age-Related Eye Disease Study (AREDS) formula, replacing beta-carotene with lutein (10 mg) and zeaxanthin (2 mg) and adding omega 3 fatty acids (1000 mg) per daily dosage. The AREDS 2 study, which is currently ongoing and expected to complete in 2013, is sponsored by the National Eye Institute/National Institutes of Health and is the second nationwide clinical study to determine whether a combination of vitamins and minerals can further slow the progression of vision loss from age-related macular degeneration (AMD). PreserVision AREDS 2 formula is one of many formulas that are being evaluated in this study.